FiercePharma

Jazz's Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow

Those who have the sleep disorder idiopathic hypersomnia finally have relief. But it comes in the form of a medicine with tight regulations and safety concerns. On Thursday, Jazz Pharmaceuticals ...
Seeking Alpha

Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024

Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral presentation of XYLO study ...
Reuters

U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

Aug 12 (Reuters) - Jazz Pharmaceuticals PLC (JAZZ.O), opens new tab said on Thursday its sleep disorder drug Xywav received U.S. regulatory approval for the expanded use in patients suffering from ...
MM&M

Jazz Pharmaceuticals, AHA sync up to hit the right note on sleep disorder awareness

For years, Jazz Pharmaceuticals and the American Heart Association (AHA) have partnered on health education, focusing specifically on raising awareness about sleep disorders. Now, Jazz said it’s ...